Trials in San Diego, California
Here are the top 10 medical studies for breast cancer in San Diego, California
Popular Filters
Phase 3 Trials
Selective Estrogen Receptor Degrader (SERD)
Camizestrant for Early Breast Cancer
Recruiting2 awardsPhase 3
San Diego, California
This trial is testing camizestrant, a drug that blocks estrogen, in patients with ER+/HER2- early breast cancer at medium to high risk of recurrence. The goal is to see if it works better than standard hormone treatments by stopping cancer cells from growing.
Estrogen Receptor Antagonist
Abemaciclib + Fulvestrant for Breast Cancer
Recruiting1 awardPhase 3
Los Alamitos, California
This trial is testing a combination of two drugs, abemaciclib and fulvestrant, for treating a specific type of breast cancer that has not responded to previous treatments. Abemaciclib is taken orally and is approved for treating certain types of breast cancer. The goal is to see if this combination can help stop the cancer from growing. The study may last several years, depending on how well the treatment works for each patient.
Chemotherapy
Chemotherapy + HER2-Targeted Therapy With or Without Hormone Therapy for Breast Cancer
Recruiting4 awardsPhase 3
San Diego, California
This trial is studying a combination of drugs given with or without hormone therapy to see how well they work in treating patients with hormone receptor-positive, HER2-positive breast cancer.
Trials With No Placebo
Selective Estrogen Receptor Degrader (SERD)
Camizestrant for Early Breast Cancer
Recruiting2 awardsPhase 3
San Diego, California
This trial is testing camizestrant, a drug that blocks estrogen, in patients with ER+/HER2- early breast cancer at medium to high risk of recurrence. The goal is to see if it works better than standard hormone treatments by stopping cancer cells from growing.
PD-L1 Inhibitor
SGN-PDL1V for Cancer
Recruiting1 awardPhase 1
Orange, California
This trial is testing a new drug, SGN-PDL1V, alone and with pembrolizumab, in patients with advanced solid tumors. The goal is to see if these treatments are safe and effective. SGN-PDL1V targets cancer cells directly, while pembrolizumab helps the immune system fight the cancer.
Monoclonal Antibodies
Immunotherapy + Hormone Therapy for Advanced Breast Cancer
Recruiting3 awardsPhase 2
Corona, California
This trial is testing a possible new treatment regimen for stage IV breast cancer that has spread. The regimen includes the immunotherapy drug pembrolizumab, and two drugs that target estrogen (fulvestrant or letrozole), plus the drug palbociclib.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.